Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

BULERIA. Repositorio Institucional de la Universidad de León
Publication Artículo científico (JournalArticle)

The impact of mycobacteria-induced trained immunity on SARS-CoV-2 vaccine responses

  • Sánchez Morales, Lidia
  • Porras, Néstor
  • Pérez Domingo, Andrea
  • Pérez Sancho, Marta
  • García Seco, Teresa
  • Díaz Frutos, Marta
  • Buendía, Aránzazu
  • Moreno, Inmaculada
  • Zamora, Leydis
  • Balseiro Morales, Ana María
  • Risalde, María A.
  • Rodríguez Bertos, Antonio
  • Gortázar, Christian
  • Domínguez, Mercedes
  • Domínguez, Lucas
[EN] Introduction: Beyond the role of Bacillus Calmette-Guérin (BCG) for tuberculosis prevention, BCG has demonstrated heterologous protective effects. The global health crisis caused by the SARS-CoV-2 virus led to research on whether BCG-induced trained immunity could strengthen antiviral defenses. However, studies reported quite different results on its effect against COVID-19. Methods and results: In this study, we evaluated the impact of pre-existing trained immunity induced by a BCG-derived Mycobacterium bovis strain (dpB), in both live and inactivated forms, in combination with SARS-CoV-2 vaccination prior to challenge in a mouse model. While the SARS-CoV-2 vaccine was enough for protection in morbidity and mortality terms, its combination with live dpB significantly enhanced immune responses reflected in higher levels of pro-inflammatory cytokines, reduced pulmonary viral loads, and improved histopathological outcomes. Additionally, the formation of inducible bronchus-associated lymphoid tissue (iBALT) in lungs in vaccinated animals pre-exposed to live dpB points to a potential mechanism for long-term immune surveillance in the respiratory tract. Conclusions: These immunological findings highlight the potential benefits of integrating trained immunity inducers with pathogen-specific vaccines to enhance immune responses and protection. Further research is needed to optimize immunomodulation strategies, dosing regimens and administration routes to maximize these synergistic effects and prevent potential negative effects, SI, The author(s) declare financial support was received for the research and/or publication of this article. LS-M holds a PhD funding (reference CT15/23) from the Universidad Complutense de Madrid and Banco Santander. LZ holds a PTA2021-021020-I funded by MICIU/AEI/10.13039/501100011033 and FSE+. This research was partially funded by a REACT-European Union grant from the Comunidad de Madrid to the ANTICIPA project of Complutense University of Madrid (reference PR38/21). Mycobacteria production was partially funded by PID2020- 112966RB-I00 financed by MCIN/AEI/10.13039/501100011033.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The impact of mycobacteria-induced trained immunity on SARS-CoV-2 vaccine responses

  • Sánchez-Morales, Lidia
  • Porras, Néstor
  • Pérez-Domingo, Andrea
  • Pérez-Sancho, Marta
  • García-Seco, Teresa
  • Díaz-Frutos, Marta
  • Buendia, Aranzazu
  • Moreno, Inmaculada
  • Zamora, Leydis
  • Balseiro, Ana
  • Risalde, María Ángeles
  • Rodriguez-Bertos, Antonio
  • Gortázar, Christian
  • Domínguez, Mercedes
  • Domínguez, Lucas
17 páginas, 9 figuras, 2 tablas., Beyond the role of Bacillus Calmette-Guérin (BCG) for tuberculosis prevention, BCG has demonstrated heterologous protective effects. The global health crisis caused by the SARS-CoV-2 virus led to research on whether BCG-induced trained immunity could strengthen antiviral defenses. However, studies reported quite different results on its effect against COVID-19., The author(s) declare financial support was received for the research and/or publication of this article. LS-M holds a PhD funding (reference CT15/23) from the Universidad Complutense de Madrid and Banco Santander. LZ holds a PTA2021-021020-I funded by MICIU/AEI/10.13039/501100011033 and FSE+. This research was partially funded by a REACT-European Union grant from the Comunidad de Madrid to the ANTICIPA project of Complutense University of Madrid (reference PR38/21). Mycobacteria production was partially funded by PID2020- 112966RB-I00 financed by MCIN/AEI/10.13039/501100011033., Authors would like to thank Marıa del Carmen Jimenez for her ́ excellent technical support. We would like to thank Luis Enjuanes for kindly providing the SARS-CoV-2 virus, the ISCIII, for their support in the cytokine analysis and MYCOTRAINING group for their support in the development of the present study, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Evaluation of trained immunity as a potential strategy for a universal Streptococcus suis vaccine using immunogenic proteins in a murine model

  • Sánchez-Morales, Lidia
  • Zamora, Leydis
  • Pérez-Sancho, Marta
  • García-Seco, Teresa
  • Moreno, Inmaculada
  • Pérez-Domingo, Andrea
  • Díaz-Frutos, Marta
  • Ciordia, Sergio
  • Buendía, Aránzazu
  • de Los Ángeles Risalde, María
  • Domínguez, Mercedes
  • Domínguez, Lucas
Universal vaccine against Streptococcus suis (S. suis) remains a challenge due to the high number of serotypes/strains, the absence of cross-protection among them and the existence of different immune escape strategies. In this study, the immunomodulatory potential of live and inactivated porcine derived Bacillus Calmette-Guérin (dpB) in combination with specific immunogenic proteins S. suis is evaluated in murine model., LSM holds a PhD funding (reference CT15/23) from the Universidad Complutense de Madrid and Banco Santander. LZ holds a PTA2021-021020-I funded by MICIU/AEI /https://doi.org/10.13039/501100011033 and FSE+. This research was funded by PID2020-112966RB-I00 project financed by MCIN/AEI/10.13039/501100011033 (TAIV-suis)., Peer reviewed, Modelo experimental animal, Mamíferos - Roedores, Organismos alternativos no vertebrados - Microorganismos Unicelulares - Bacterias